Ginkgo biloba leaf extract injection quality control method based on quantitative analysis of multi-components by single marker and fingerprint spectrum
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HEILONGJIANG ZBD PHARMA
- Publication Date
- 2017-08-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for controlling the quality of Shuxuening injection based on a one-measurement-multiple-assessment method and a fingerprint. Background technique
[0002] Shuxuening Injection dilates blood vessels and improves microcirculation. For ischemic cardiovascular and cerebrovascular diseases, coronary heart disease, angina pectoris, cerebral embolism, cerebral vasospasm, etc. The raw material is Ginkgo biloba, and the excipients are glucose and ethanol. Every 2 mL of Shuxuening injection contains 7.0 mg of Ginkgo biloba extract, which contains 1.68 mg of total flavonol glycosides and 0.28 mg of ginkgo biloba lactone.
[0003] The fingerprint of traditional Chinese medicine refers to the chromatogram or spectrum of a certain type or several types of components that are common in certain Chinese medicinal materials or Chinese patent medicines. At the present stage, when most of the active ingredients of traditional Chinese me...